Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.

Moghadas, Seyed M; Shoukat, Affan; Bawden, Carolyn E; Langley, Joanne M; Singer, Burton H; Fitzpatrick, Meagan C; Galvani, Alison P.

Affiliation

Moghadas SM; Agent-Based Modelling Laboratory, York University, Toronto, Ontario, Canada.
Shoukat A; Agent-Based Modelling Laboratory, York University, Toronto, Ontario, Canada.
Bawden CE; Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
Langley JM; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, Nova Scotia, Canada.
Singer BH; Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
Fitzpatrick MC; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Galvani AP; Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, Connecticut, USA.

Clin Infect Dis ; 2023 Nov 30.

Article in En | MEDLINE | ID: mdl-38035791